CleanSpace Holdings Ltd (ASX:CSX) is a designer and manufacturer of powered air-purifying respirators (PAPRs).
CSX has reported its FY26 result with revenue in line with the previous corresponding period (pcp) at $19.8m and an adjusted EBITDA loss of $0.6m, compared with -$0.1m in the pcp.
The result was well flagged and impacted by delays to a new product launch (AGILE), trade disputes and the dismantling of the US regulator (NIOSH), which saw US H2 FY26 revenue decline 53%, as well as tighter Australian regulations impacting H1 orders.
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
Cleanspace Holdings Ltd - Plenty to be excited about into FY27